pRSFDuet-gst-xr
(Plasmid
#214761)
-
PurposeXylose reductase from Hypocrea jecorina fused with GST-tagged and codon optimized for expression in E. coli
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 214761 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRSFDuet-1
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 3829
- Total vector size (bp) 5485
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameglutathione S-transferases fused with xylose reductase
-
Alt namegst-xyl
-
Alt namegst-xr
-
SpeciesHypocrea jecorina
-
Insert Size (bp)1658
- Promoter T7
-
Tag
/ Fusion Protein
- Glutathione S-transferases (N terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer GTATAAGAAGGAGATATACAATGTCCCCTATACTAGGTTATTG
- 3′ sequencing primer TATCCAATTGAGATCTGCCAAATTCTTAACCAAACAGGTAC (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pRSFDuet-gst-xr was a gift from Pimchai Chaiyen (Addgene plasmid # 214761 ; http://n2t.net/addgene:214761 ; RRID:Addgene_214761) -
For your References section:
A versatile in situ cofactor enhancing system for meeting cellular demands for engineered metabolic pathways. Jaroensuk J, Sutthaphirom C, Phonbuppha J, Chinantuya W, Kesornpun C, Akeratchatapan N, Kittipanukul N, Phatinuwat K, Atichartpongkul S, Fuangthong M, Pongtharangkul T, Hollmann F, Chaiyen P. J Biol Chem. 2023 Dec 28:105598. doi: 10.1016/j.jbc.2023.105598. 10.1016/j.jbc.2023.105598 PubMed 38159859